We, therefore, aimed to rigorously evaluate the single‐installation BLEO‐IPF mouse model for reproducible lung disease phenotype and TGFβ‐targeted drug therapeutic outcomes using a wide array of state‐of‐the‐art lung functional, biochemical and histological methods. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.